Clinical Trial Update: Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 bioequivalence study comparing generic saquinavir with ritonavir to branded saquinavir (Invirase) with ritonavir has been withdrawn. The study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Generic GPO Saquinavir (saquinavir)
• Invirase (saquinavir)
• Norvir (ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 1, Phase 2 | Status: WITHDRAWN